Alliancebernstein L.P. Sells 1,721 Shares of Simulations Plus, Inc. (NASDAQ:SLP)

Alliancebernstein L.P. reduced its position in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 11.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 13,879 shares of the technology company’s stock after selling 1,721 shares during the period. Alliancebernstein L.P.’s holdings in Simulations Plus were worth $387,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Jones Financial Companies Lllp increased its holdings in shares of Simulations Plus by 53.6% during the fourth quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company’s stock worth $34,000 after buying an additional 427 shares in the last quarter. AlphaQuest LLC increased its holdings in Simulations Plus by 502.9% during the 4th quarter. AlphaQuest LLC now owns 2,689 shares of the technology company’s stock valued at $75,000 after purchasing an additional 2,243 shares in the last quarter. KLP Kapitalforvaltning AS bought a new position in Simulations Plus in the 4th quarter valued at $86,000. Quantbot Technologies LP boosted its stake in Simulations Plus by 191.6% in the fourth quarter. Quantbot Technologies LP now owns 5,371 shares of the technology company’s stock worth $150,000 after purchasing an additional 3,529 shares in the last quarter. Finally, US Bancorp DE grew its holdings in shares of Simulations Plus by 14.3% during the fourth quarter. US Bancorp DE now owns 5,687 shares of the technology company’s stock worth $159,000 after purchasing an additional 713 shares during the last quarter. 78.08% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. StockNews.com cut Simulations Plus from a “hold” rating to a “sell” rating in a report on Monday, April 14th. William Blair reiterated an “outperform” rating on shares of Simulations Plus in a research report on Wednesday, January 8th. Finally, KeyCorp raised their price target on Simulations Plus from $32.00 to $40.00 and gave the company an “overweight” rating in a report on Wednesday, April 16th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Simulations Plus has a consensus rating of “Moderate Buy” and a consensus target price of $50.00.

Insider Buying and Selling

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $33.91, for a total value of $678,200.00. Following the transaction, the director now owns 3,402,584 shares of the company’s stock, valued at approximately $115,381,623.44. The trade was a 0.58 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 19.40% of the stock is currently owned by company insiders.

Simulations Plus Trading Up 1.5 %

Simulations Plus stock opened at $32.69 on Monday. The firm has a market capitalization of $657.43 million, a P/E ratio of 81.73 and a beta of 1.13. The business has a 50-day moving average of $28.55 and a 200-day moving average of $30.08. Simulations Plus, Inc. has a 1 year low of $23.01 and a 1 year high of $51.22.

Simulations Plus (NASDAQ:SLP) last issued its earnings results on Thursday, April 3rd. The technology company reported $0.31 EPS for the quarter, beating the consensus estimate of $0.25 by $0.06. The firm had revenue of $22.43 million during the quarter, compared to the consensus estimate of $21.93 million. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The business’s quarterly revenue was up 22.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.20 earnings per share. Research analysts anticipate that Simulations Plus, Inc. will post 1.09 EPS for the current fiscal year.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.